1,394
|
9961 |
Schizophrenia
|
|
decreases_expression of
|
CLOCK
|
|
|
16223876
|
Schizophrenia
|
1,740
|
13062 |
CLOCK
|
|
increases_expression of
|
PAX6
|
|
|
15254898
|
Neurological
|
4,230
|
43220 |
CLOCK
|
|
affects_activity of
|
circadian rhythm
|
in ventral tegmental area
|
43221 |
CLOCK
|
|
affects_expression of
|
CACNG5
|
in ventral tegmental area
|
43223 |
CLOCK
|
|
affects_expression of
|
CHRNB4
|
in ventral tegmental area
|
|
20591414
|
Bipolar disorder
Major depressive disorder
Circadian rhythm
|
4,462
|
45299 |
PPARGC1A
|
|
increases_expression of
|
CLOCK
|
|
|
17476214
|
Diabetes mellitus, type II
Insulin resistance
|
5,327
|
52078 |
FOXO3
|
|
increases_expression of
|
CLOCK
|
in liver
|
52079 |
CLOCK
|
|
affects_activity of
|
circadian rhythm
|
|
|
24856209
|
Metabolic
Sleep disorders
|
6,387
|
61628 |
CLOCK
|
|
is_part_of
|
CLOCK-BMAL1 complex
|
|
|
25955819
|
Metabolic
|
6,456
|
61411 |
CLOCK
|
|
affects_activity of
|
circadian rhythm
|
|
61420 |
Metformin
|
|
increases_expression of
|
CLOCK
|
via AMPK/NAMPT/SIRT1 signaling
|
|
22117616
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
6,583
|
63417 |
CLOCK
|
|
is_part_of
|
Core clock complex
|
|
63470 |
CLOCK
|
|
affects_activity of
|
polyphagia
|
|
63471 |
CLOCK
|
|
affects_activity of
|
hyperlipidemia
|
|
63472 |
CLOCK
|
|
affects_activity of
|
hyperglycemia
|
|
63473 |
CLOCK
|
|
affects_activity of
|
decreased circulating insulin level
|
|
63480 |
CLOCK
|
|
affects_activity of
|
Diabetes mellitus, type II
|
|
63516 |
circadian rhythm
|
|
affects_expression of
|
CLOCK
|
in pancreas
|
|
25457619
|
Diabetes mellitus, type II
Insulin resistance
|
6,590
|
63321 |
Metformin
|
|
affects_activity of
|
CLOCK
|
in liver; via circadian rhythm
|
63328 |
Metformin
|
NOT |
affects_activity of
|
CLOCK
|
in muscle; via circadian rhythm
|
63332 |
circadian rhythm
|
|
affects_quantity of
|
CLOCK
|
in liver, in muscle
|
63340 |
Metformin
|
|
increases_expression of
|
CLOCK
|
in liver, in muscle
|
|
22968146
|
Diabetes mellitus, type II
Insulin resistance
|
6,706
|
64764 |
CLOCK
|
|
increases_expression of
|
F7
|
|
|
18316400
|
Myocardial infarction
|
6,721
|
64931 |
CLOCK
|
|
affects_activity of
|
circadian rhythm
|
|
64963 |
CLOCK
|
|
interacts (colocalizes) with
|
EP300
|
|
64965 |
CLOCK
|
|
interacts (colocalizes) with
|
KAT2B
|
|
64982 |
CLOCK
|
|
increases_activity of
|
histone acetylation
|
|
64983 |
CLOCK
|
|
affects_expression of
|
DBP
|
via histone acetylation
|
64984 |
CLOCK
|
|
affects_expression of
|
PER1
|
via histone acetylation
|
65018 |
CLOCK
|
|
interacts (colocalizes) with
|
KMT2A
|
|
65021 |
CLOCK
|
|
increases_activity of
|
KMT2A
|
|
65050 |
CLOCK
|
|
increases_acetylation of
|
ARNTL
|
|
65051 |
CLOCK
|
|
increases_activity of
|
CRY1
|
|
65053 |
CLOCK
|
|
affects_activity of
|
NR3C1
|
via acetylation
|
65056 |
CLOCK
|
|
affects_activity of
|
response to glucocorticoid
|
via acetylation of NR3C1
|
65077 |
CLOCK
|
|
affects_activity of
|
hyperglycemia
|
|
65078 |
CLOCK
|
|
affects_activity of
|
decreased circulating insulin level
|
|
65094 |
CLOCK
|
|
affects_activity of
|
hepatic steatosis
|
|
65096 |
CLOCK
|
|
affects_activity of
|
lipid metabolic process
|
|
65145 |
PARP1
|
|
affects_activity of
|
CLOCK
|
|
|
22841001
|
Diabetes mellitus, type II
Insulin resistance
|
6,747
|
65694 |
CLOCK
|
|
affects_activity of
|
increased triglyceride level
|
|
65695 |
CLOCK
|
|
affects_activity of
|
hepatic steatosis
|
|
|
27230643
|
Diabetes mellitus, type II
Insulin resistance
Cardiomyopathy, diabetic
|
6,858
|
66800 |
CLOCK
|
|
affects_activity of
|
insulin secretion
|
|
66802 |
CLOCK
|
|
affects_activity of
|
glucose homeostasis
|
|
|
26331226
|
Diabetes mellitus, type II
Insulin resistance
|
6,861
|
66828 |
CLOCK
|
|
increases_activity of
|
entrainment of circadian clock
|
|
66838 |
CLOCK
|
|
increases_expression of
|
ARNTL
|
|
66856 |
CLOCK
|
|
increases_expression of
|
GYS
|
with a peak in the active period
|
66857 |
CLOCK
|
|
increases_expression of
|
PYG
|
with a peak in the resting period
|
66915 |
CLOCK
|
|
affects_activity of
|
abnormal circadian feeding behavior
|
|
66916 |
CLOCK
|
|
affects_activity of
|
abnormal energy homeostasis
|
|
66917 |
CLOCK
|
|
affects_activity of
|
hyperglycemia
|
|
66918 |
CLOCK
|
|
affects_activity of
|
decreased circulating insulin level
|
|
66919 |
CLOCK
|
|
affects_activity of
|
insulin receptor signaling pathway
|
|
66926 |
CLOCK
|
|
affects_activity of
|
leptin-mediated signaling pathway
|
|
67030 |
CLOCK
|
|
affects_expression of
|
mir-219
|
|
67054 |
mir-107
|
|
decreases_expression of
|
CLOCK
|
|
|
26927084
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
7,314
|
71853 |
RAI1
|
|
increases_expression of
|
CLOCK
|
|
|
22578325
|
Diabetes mellitus, type II
Insulin resistance
|
7,434
|
73078 |
CLOCK
|
|
decreases_expression of
|
COL1A1
|
in kidney
|
73080 |
CLOCK
|
|
decreases_expression of
|
COL4A1
|
in kidney
|
73081 |
CLOCK
|
|
decreases_expression of
|
Collagen
|
in kidney
|
73196 |
CLOCK
|
|
increases_expression of
|
TGFB1
|
in embryonic fibroblasts
|
73201 |
CLOCK
|
|
decreases_activity of
|
response to oxidative stress
|
in renal tubular cells
|
|
26458764
|
Renal
Inflammation
|
7,447
|
73304 |
mir-107
|
|
affects_activity of
|
CLOCK
|
|
|
25522185
|
Diabetes mellitus, type II
Insulin resistance
Atherosclerosis
|
7,467
|
73673 |
ARNTL
|
|
interacts (colocalizes) with
|
CLOCK
|
|
|
9576906
|
Diabetes mellitus, type II
Insulin resistance
|
7,521
|
74300 |
CLOCK
|
|
affects_activity of
|
Cardiomyopathy, dilated
|
|
74301 |
CLOCK
|
|
affects_activity of
|
abnormal vascular endothelial cell physiology
|
|
74302 |
CLOCK
|
|
affects_activity of
|
atherosclerotic lesions
|
|
74303 |
CLOCK
|
|
affects_activity of
|
cholesterol metabolic process
|
|
|
25883568
|
Cardiovascular disease
Atherosclerosis
|
7,526
|
75633 |
CLOCK
|
|
interacts (colocalizes) with
|
PER (E-Box, promoter)
|
|
75634 |
CLOCK
|
|
interacts (colocalizes) with
|
CRY (E-Box, promoter)
|
|
75641 |
CLOCK
|
|
is_part_of
|
CLOCK-BMAL1 complex
|
|
75649 |
NR1D1
|
|
decreases_expression of
|
CLOCK
|
|
75652 |
RORA
|
|
increases_expression of
|
CLOCK
|
|
75671 |
NAD/NADH ratio
|
|
affects_activity of
|
CLOCK
|
|
83297 |
PER-CRY complex
|
|
decreases_expression of
|
CLOCK
|
|
|
25073467
|
Gastrointestinal
Metabolic
|
7,593
|
75866 |
Obesity
|
|
affects_expression of
|
CLOCK
|
via methylation at CpG sites
|
75869 |
CLOCK
|
|
affects_activity of
|
decreased susceptibility to weight loss
|
via methylation at CpG sites
|
75871 |
Monounsaturated fatty acid
|
|
affects_expression of
|
CLOCK
|
via methylation at CpG sites
|
75872 |
Polyunsaturated fatty acid
|
|
affects_expression of
|
CLOCK
|
via methylation at CpG sites
|
|
23003921
|
Diabetes mellitus, type II
Obesity
Insulin resistance
|
8,247
|
83283 |
CLOCK
|
|
affects_activity of
|
Core clock complex
|
|
83294 |
ARNTL
|
|
interacts (colocalizes) with
|
CLOCK
|
|
83298 |
CLOCK
|
|
is_part_of
|
Core clock complex
|
|
|
21613214
|
Metabolic
|
8,555
|
88007 |
maternal obesity
|
|
affects_activity of
|
CLOCK
|
in pancreas
|
|
24657938
|
Diabetes mellitus, type II
Insulin resistance
Fatty pancreas disease, nonalcoholic
|
9,629
|
101677 |
CLOCK
|
|
is_part_of
|
Core clock complex
|
in the liver
|
|
30659595
|
Inflammation
|
10,295
|
106793 |
CLOCK
|
NOT |
affects_expression of
|
SLC6A4
|
in the mouse midbrain
|
|
22572884
|
Neurological
Metabolic
|